Zongertinib

Modify Date: 2024-01-02 21:15:55

Zongertinib structure	Common Name	Zongertinib
	CAS Number	2728667-27-2	Molecular Weight	535.60
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₂₉H₂₉N₉O₂	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of Zongertinib

Zongertinib is a potent tyrosine kinase inhibitor. Zongertinib can be used as an antineoplastic agent. Zongertinib also has been tested as pHER2 and EGFR inhibitor inhibiting a wide variety of cancers[1][2].

Name	Zongertinib

Description	Zongertinib is a potent tyrosine kinase inhibitor. Zongertinib can be used as an antineoplastic agent. Zongertinib also has been tested as pHER2 and EGFR inhibitor inhibiting a wide variety of cancers[1][2].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Protein Tyrosine Kinase/RTK >> c-Met/HGFR
References	[1]. WHO Drug Informat ion - World Health Organization (WHO). [2]. Wilding Birgit, et al. Synthesis of diazino-pyrimidines as anticancer agents: World Intellectual Property Organization, WO2021213800. 2021-10-28. [3]. WHO Drug Information-World Health Organization (WHO).

Description

Related Catalog

Research Areas >> Cancer

Signaling Pathways >> Protein Tyrosine Kinase/RTK >> c-Met/HGFR

References

[1]. WHO Drug Informat ion - World Health Organization (WHO).

[2]. Wilding Birgit, et al. Synthesis of diazino-pyrimidines as anticancer agents: World Intellectual Property Organization, WO2021213800. 2021-10-28.

[3]. WHO Drug Information-World Health Organization (WHO).